ClinVar Miner

Submissions for variant NM_000233.4(LHCGR):c.1733A>G (p.Asp578Gly)

dbSNP: rs121912518
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 6
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Athena Diagnostics RCV000517056 SCV000614017 pathogenic not provided 2024-11-01 criteria provided, single submitter clinical testing This variant has not been reported in large, multi-ethnic general populations. (http://gnomad.broadinstitute.org) This variant segregates with familial male precocious puberty in at least one family. Assessment of experimental evidence suggests this variant results in abnormal protein function. This variant results in constitutively active cAMP signaling (PMID: 7692306, 7714085, 8943222, 21490077). At least one other missense variant at this codon is considered to be pathogenic or likely pathogenic, suggesting this variant may also cause disease.
Fulgent Genetics, Fulgent Genetics RCV000763499 SCV000894285 pathogenic Leydig cell agenesis; Gonadotropin-independent familial sexual precocity 2018-10-31 criteria provided, single submitter clinical testing
GeneDx RCV000517056 SCV001812796 pathogenic not provided 2024-12-10 criteria provided, single submitter clinical testing Published functional studies demonstrate that p.(D578G) is an activating variant (PMID: 21490077, 7692306); Male members of a knock-in mouse model demonstrated precocious puberty (PMID: 23861372); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 7692306, 8943222, 9703386, 26040673, 7714085, 7527413, 8855841, 21490077, 7562970, 30283825, 23861372)
Labcorp Genetics (formerly Invitae), Labcorp RCV000517056 SCV002218734 pathogenic not provided 2024-10-17 criteria provided, single submitter clinical testing This sequence change replaces aspartic acid, which is acidic and polar, with glycine, which is neutral and non-polar, at codon 578 of the LHCGR protein (p.Asp578Gly). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with autosomal dominant precocious puberty (PMID: 7692306, 30283825). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 14384). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt LHCGR protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects LHCGR function (PMID: 7692306, 21490077, 23861372). For these reasons, this variant has been classified as Pathogenic.
OMIM RCV000015461 SCV000035726 pathogenic Gonadotropin-independent familial sexual precocity 1998-07-01 no assertion criteria provided literature only
Clinical Molecular Genetics Laboratory, Johns Hopkins All Children's Hospital RCV000583503 SCV000692111 pathogenic Precocious puberty in males 2012-11-09 no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.